Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delbert G Robinson

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Biological Psychology|December 15, 2007
DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophreniaPhilip R Szeszko, Colin A Hodgkinson, Delbert G Robinson, et al.
Psychiatric Services (Washington, D.C.)|June 2, 2017
Perceived Autonomy Support in the NIMH RAISE Early Treatment ProgramJulia Browne, David L Penn, Daniel J Bauer, et al.
Schizophrenia Research|April 2, 2025
The problem of missing data for learning health systems focused on first-episode psychosisDelbert G Robinson, Nina R Schooler, Majnu John, et al.
Schizophrenia Research|September 23, 2018
A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidoneDelbert G Robinson, Juan A Gallego, Majnu John, et al.
The Journal of Clinical Psychiatry|April 2, 2015
The RAISE early treatment program for first-episode psychosis: background, rationale, and study designJohn M Kane, Nina R Schooler, Patricia Marcy, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 3, 2007
Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophreniaPhilip R Szeszko, Delbert G Robinson, Serge Sevy, et al.
Psychiatric Services (Washington, D.C.)|January 5, 2016
Coordinated Technology-Delivered Treatment to Prevent Rehospitalization in Schizophrenia: A Novel Model of CareMary F Brunette, Armando J Rotondi, Dror Ben-Zeev, et al.
Schizophrenia Bulletin|May 25, 2016
Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysisJian-Ping Zhang, Todd Lencz, Ryan X Zhang, et al.
Pharmacogenetics and Genomics|March 2, 2016
The identification of novel genetic variants associated with antipsychotic treatment response outcomes in first-episode schizophrenia patientsBritt I Drögemöller, Robin Emsley, Bonginkosi Chiliza, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 22, 2007
Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophreniaPhilip R Szeszko, Delbert G Robinson, Manzar Ashtari, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Biological Psychology|December 15, 2007
DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophreniaPhilip R Szeszko, Colin A Hodgkinson, Delbert G Robinson, et al.
Psychiatric Services (Washington, D.C.)|June 2, 2017
Perceived Autonomy Support in the NIMH RAISE Early Treatment ProgramJulia Browne, David L Penn, Daniel J Bauer, et al.
Schizophrenia Research|April 2, 2025
The problem of missing data for learning health systems focused on first-episode psychosisDelbert G Robinson, Nina R Schooler, Majnu John, et al.
Schizophrenia Research|September 23, 2018
A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidoneDelbert G Robinson, Juan A Gallego, Majnu John, et al.
The Journal of Clinical Psychiatry|April 2, 2015
The RAISE early treatment program for first-episode psychosis: background, rationale, and study designJohn M Kane, Nina R Schooler, Patricia Marcy, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 3, 2007
Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophreniaPhilip R Szeszko, Delbert G Robinson, Serge Sevy, et al.
Psychiatric Services (Washington, D.C.)|January 5, 2016
Coordinated Technology-Delivered Treatment to Prevent Rehospitalization in Schizophrenia: A Novel Model of CareMary F Brunette, Armando J Rotondi, Dror Ben-Zeev, et al.
Schizophrenia Bulletin|May 25, 2016
Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysisJian-Ping Zhang, Todd Lencz, Ryan X Zhang, et al.
Pharmacogenetics and Genomics|March 2, 2016
The identification of novel genetic variants associated with antipsychotic treatment response outcomes in first-episode schizophrenia patientsBritt I Drögemöller, Robin Emsley, Bonginkosi Chiliza, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 22, 2007
Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophreniaPhilip R Szeszko, Delbert G Robinson, Manzar Ashtari, et al.
Pageof 11